News Roundup Sam Ghilardi 8/18/26 News Roundup Sam Ghilardi 8/18/26 LifeMine Closes Watertown's Largest Funding Round of 2026 and EyePoint's Phase 3 Miss Plus a flurry of clinical trial updates and quarterly reports Read More
News Roundup Sam Ghilardi 8/18/26 News Roundup Sam Ghilardi 8/18/26 LifeMine Closes Watertown's Largest Funding Round of 2026 and EyePoint's Phase 3 Miss Plus a flurry of clinical trial updates and quarterly reports Read More